FOLIC ACID AND RAMIPRIL COMBINATION: CYTO-PROTECTIVE, NEURO-PROTECTIVE AND RETIN-PROTECTIVE OPHTHALMOLOGICAL COMPOSITIONS

摘要

1. A composition characterized in that it contains at least two active components selected from an angiotensin converting enzyme inhibitor (ACE inhibitor), folic acid, folate, magnesium, potassium, glucose, amino acids (especially leucine, and in particular acetyleucine), L-arginine , tetrahydrobiopterin (H4B), vitamin B6, vitamin B12, vitamin C, w-3 fatty acids, anti-inflammatory agents, beta-blocking agents, epinephrine, norepinephrine, alpha adrenergic agonist agents, anti-growth factor agents and vascular endothelial (anti-VEGF), their pharmaceutically acceptable salts or derivatives thereof and smesey.2. The composition according to claim 1, which contains: a) a first active component that essentially consists of or consists of ACE inhibitors, and b) a second active component that is selected from folic acid, folate, magnesium, potassium, glucose, amino acids ( especially leucine, and in particular acetyleucine), one of their pharmaceutically acceptable salts, their derivatives and mixtures thereof, and c) optionally, a third active component that is selected from L-arginine, H4B, vitamin B6, vitamin B12, vitamin C, w- 3 fatty acids, anti-inflammatory agents, beta blocking agents, hell enalina, noradrenaline, agents representing alpha-adrenergic agonists, anti-VEGF agents and their smesey.3. The composition according to claim 1 or 2, characterized in that the ACE inhibitor contains essentially consists of or consists of ramipril, ramiprilat, one of their pharmaceutically acceptable salts or any derivative of ramipril or ramiprilat, which can release ramipril or ramiprilat in the animal’s body, to which the indicated active com